Walgreens Announces New Vaccination and Testing Offerings Ahead of Fall Respiratory Virus Season
Views:
1970-01-01 08:00
DEERFIELD, Ill.--(BUSINESS WIRE)--Aug 16, 2023--

DEERFIELD, Ill.--(BUSINESS WIRE)--Aug 16, 2023--

Walgreens is offering in-store vouchers and off-site vaccination clinics through its employer vaccination program, and is rolling out a low-cost, 2 results in 1 test for flu and COVID-19 this fall respiratory virus season. These new services support insights gleaned from a recent consumer survey commissioned by Walgreens that reveals many prefer going to local pharmacies because of their ease and convenience. 1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230816575526/en/

Walgreens is offering in-store vouchers and off-site vaccination clinics through its employer vaccination program, and is rolling out a low-cost, 2 results in 1 test for flu and COVID-19 this fall respiratory virus season. (Photo: Business Wire)

Key findings from a survey of more than 1,000 adult consumers include:

“These insights demonstrate that people recognize pharmacies as a convenient and easy place to receive vaccinations,” said Kevin Ban, MD, Chief Medical Officer, Walgreens. “To meet this demand, we are removing friction to help keep our communities protected this fall. Our expert pharmacists are prepared to ensure everyone gets the appropriate prevention, testing or treatment they need this season through offerings such as our in-store vouchers for employees or new, low-cost 2 results in 1 test for COVID-19 and flu.”

Walgreens’ new services will help communities to get ahead of respiratory virus season with accessible and timely options for vaccination, testing and treatment all in one place.

Walgreens is offering flu and respiratory syncytial virus (RSV) vaccination appointments nationwide and will provide the new Centers for Disease Control and Prevention (CDC) recommended COVID-19 vaccine once available later this fall.

To make a vaccination or testing appointment, individuals can visit Walgreens.com/ScheduleVaccine or Walgreens.com/Testing, download the Walgreens app or call 1-800-WALGREENS.

About Walgreens

Walgreens ( www.walgreens.com ) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.

1 KRC Research conducted the immunization study using an online omnibus survey of n=1,010 U.S. adults ages 18+. This survey was conducted from July 24 to July 26, 2023.

2 Centers for Disease Control and Prevention. “CDC Tracks Ongoing Flu Activity in the Southern Hemisphere.” June 23, 2023. https://www.cdc.gov/flu/spotlights/2022-2023/ongoing-flu-southern-hemisphere.htm

View source version on businesswire.com:https://www.businesswire.com/news/home/20230816575526/en/

CONTACT: Stephanie Corcilius

Walgreens Media Relations

media@walgreens.com

KEYWORD: ILLINOIS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: RETAIL HEALTH INFECTIOUS DISEASES CONVENIENCE STORE GENERAL HEALTH PHARMACEUTICAL

SOURCE: Walgreens

Copyright Business Wire 2023.

PUB: 08/16/2023 09:00 AM/DISC: 08/16/2023 09:01 AM

http://www.businesswire.com/news/home/20230816575526/en

Tags epus finance coronavirus